Bio-Reference Laboratories (BRLI +9.1%) pops after beating FQ1 estimates earlier. Revenue jumped...

|About: Bio-Reference Laboratories,... (BRLI)|By:, SA News Editor

Bio-Reference Laboratories (BRLI +9.1%) pops after beating FQ1 estimates earlier. Revenue jumped 23% Y/Y on double digit sales growth as the clinical-testing company's patient count has risen and its share of complex, non-routine testing services continues to grow.